Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Fedele

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expressionGennaro Chiappetta, Gerardo Botti, Mario Monaco, et al.
Molecular Endocrinology (Baltimore, Md.)|June 30, 2012
The HMGA1-IGF-I/IGFBP system: a novel pathway for modulating glucose uptakeStefania Iiritano, Eusebio Chiefari, Valeria Ventura, et al.
Oncogene|March 1, 2005
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomasMonica Fedele, Francesca Pentimalli, Gustavo Baldassarre, et al.
Oncogene|June 26, 2002
Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomasMonica Fedele, Sabrina Battista, Lawrence Kenyon, et al.
Oncotarget|January 18, 2015
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migrationGennaro Chiappetta, Teresa Valentino, Michela Vitiello, et al.
Cancers|April 13, 2023
PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant PhenotypeStefano Lucà, Renato Franco, Antonella Napolitano, et al.
Bioactive Materials|May 9, 2025
A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growthAlessandra Caliendo, Simona Camorani, Luis Exequiel Ibarra, et al.
Biology Open|September 6, 2014
CBX7 gene expression plays a negative role in adipocyte cell growth and differentiationFloriana Forzati, Antonella Federico, Pierlorenzo Pallante, et al.
Scientific Reports|December 20, 2016
A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expressionEusebio Chiefari, Valeria Ventura, Carmelo Capula, et al.
Oncotarget|September 24, 2017
PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtypeElia Guadagno, Michela Vitiello, Paola Francesca, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expressionGennaro Chiappetta, Gerardo Botti, Mario Monaco, et al.
Molecular Endocrinology (Baltimore, Md.)|June 30, 2012
The HMGA1-IGF-I/IGFBP system: a novel pathway for modulating glucose uptakeStefania Iiritano, Eusebio Chiefari, Valeria Ventura, et al.
Oncogene|March 1, 2005
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomasMonica Fedele, Francesca Pentimalli, Gustavo Baldassarre, et al.
Oncogene|June 26, 2002
Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomasMonica Fedele, Sabrina Battista, Lawrence Kenyon, et al.
Oncotarget|January 18, 2015
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migrationGennaro Chiappetta, Teresa Valentino, Michela Vitiello, et al.
Cancers|April 13, 2023
PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant PhenotypeStefano Lucà, Renato Franco, Antonella Napolitano, et al.
Bioactive Materials|May 9, 2025
A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growthAlessandra Caliendo, Simona Camorani, Luis Exequiel Ibarra, et al.
Biology Open|September 6, 2014
CBX7 gene expression plays a negative role in adipocyte cell growth and differentiationFloriana Forzati, Antonella Federico, Pierlorenzo Pallante, et al.
Scientific Reports|December 20, 2016
A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expressionEusebio Chiefari, Valeria Ventura, Carmelo Capula, et al.
Oncotarget|September 24, 2017
PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtypeElia Guadagno, Michela Vitiello, Paola Francesca, et al.
Pageof 10